- Home
- USFD vs RPRX Comparison
USFD vs RPRX Comparison
Compare USFD & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USFD | RPRX |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0B | 25.9B |
| IPO Year | 2016 | 2020 |
Fundamental Metrics
Financial Performance| Metric | USFD | RPRX |
|---|---|---|
| Price | $103.61 | $60.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | ★ $103.64 | $51.40 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.90% |
| EPS Growth | ★ 45.54 | N/A |
| EPS | ★ 1.76 | 0.71 |
| Revenue | ★ $39,424,000,000.00 | $2,378,193,000.00 |
| Revenue This Year | $7.63 | $38.63 |
| Revenue Next Year | $3.92 | $4.73 |
| P/E Ratio | ★ $59.11 | $90.08 |
| Revenue Growth | 4.08 | ★ 5.06 |
| 52 Week Low | $69.88 | $34.63 |
| 52 Week High | $111.42 | $64.38 |
Technical Indicators
Market Signals| Indicator | USFD | RPRX |
|---|---|---|
| Relative Strength Index (RSI) | 44.31 | 49.25 |
| Support Level | $88.34 | $55.66 |
| Resistance Level | $111.35 | $60.44 |
| Average True Range (ATR) | 2.29 | 1.34 |
| MACD | -0.93 | -0.01 |
| Stochastic Oscillator | 13.73 | 31.30 |
Price Performance
Historical ComparisonAbout USFD US Foods Holding Corp.
US Foods is a leading domestic foodservice distributor, generating $39 billion in sales in fiscal 2025 and capturing a 10% share of the fragmented industry. The firm sells and distributes more than 350,000 food and nonfood products to about 250,000 customer locations, including independent restaurants (33% of fiscal 2025 sales), chain restaurants (23%), healthcare and hospitality clients (27%), and other end markets (17%), largely consisting of education and government contracts. US Foods also operates 98 cash-and-carry locations under the Chef'Store banner. The firm's physical network spans 76 distribution facilities and 14 broadline production centers.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.